3,072 hedge funds and large institutions have $169B invested in Pfizer in 2022 Q3 according to their latest regulatory filings, with 138 funds opening new positions, 1,351 increasing their positions, 1,225 reducing their positions, and 168 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less funds holding

Funds holding:

16% less capital invested

Capital invested by funds: $201B → $169B (-$32B)

18% less first-time investments, than exits

New positions opened: 138 | Existing positions closed: 168

38% less funds holding in top 10

Funds holding in top 10: 251156 (-95)

Holders
3,072
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
156
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.73B
Puts
$2.07B
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$21.6B
2
$18.9B
3
$12.6B
4
$10.9B
5
$9.23B
6
$4.83B
7
$3.15B
8
$3.07B
9
$2.91B
10
$2.68B
11
$2.53B
12
$2.48B
13
$2.42B
14
$2.34B
15
$1.83B
16
$1.81B
17
$1.8B
18
$1.73B
19
$1.6B
20
$1.59B
21
$1.4B
22
$1.09B
23
$1.06B
24
$1.02B
25
$980M